Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer von SPIGEL, David R, ERVIN, Thomas J, GOVINDAN, Ramaswamy, PATEL, Taral, ORLOV, Sergey V, WERTHEIM, Michael S, WEI YU, JIPING ZHA, YAUCH, Robert L, PATEL, Premal H, PHAN, See-Chun, PETERSON, Amy C, RAMLAU, Rodryg A, DANIEL, Davey B, GOLDSCHMIDT, Jerome H, BLUMENSCHEIN, George R, KRZAKOWSKI, Maciej J, ROBINET, Gilles, GODBERT, Benoit, BARLESI, Fabrice

Volltext

BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma von KIM, Kevin B, SOSMAN, Jeffrey A, PETERSON, Amy C, CARSON, William E, O'DAY, Steven J, FRUEHAUF, John P, LINETTE, Gerald P, MARKOVIC, Svetomir N, MCDERMOTT, David F, WEBER, Jeffrey S, NGUYEN, Hoa, CHEVERTON, Peter, CHEN, Daniel

Volltext

Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment von HARLIN, Helena, YURU MENG, PETERSON, Amy C, YUANYUAN ZHA, TRETIAKOVA, Maria, SLINGLUFF, Craig, MCKEE, Mark, GAJEWSKI, Thomas F

Volltext

Immunization With Melan-A Peptide-Pulsed Peripheral Blood Mononuclear Cells Plus Recombinant Human Interleukin-12 Induces Clinical Activity and T-Cell Responses in Advanced Melanom... von PETERSON, Amy C, HARLIN, Helena, GAJEWSKI, Thomas F

Volltext

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells von BLANK, Christian, BROWN, Ian, PETERSON, Amy C, SPIOTTO, Mike, IWAI, Yoshiko, HONJO, Tasuku, GAJEWSKI, Thomas F

Volltext

A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer von Schwartzberg, Lee S, Yardley, Denise A, Elias, Anthony D, Patel, Manish, LoRusso, Patricia, Burris, Howard A, Gucalp, Ayca, Peterson, Amy C, Blaney, Martha E, Steinberg, Joyce L, Gibbons, Jacqueline A, Traina, Tiffany A

Volltext

Phase II Study of the Flk-1 Tyrosine Kinase Inhibitor SU5416 in Advanced Melanoma von PETERSON, Amy C, SWIGER, Susan, STADLER, Walter M, MEDVED, Milica, KARCZMAR, Greg, GAJEWSKI, Thomas F

Volltext

T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-α von Gajewski, Thomas F, Zha, Yuanyuan, Marks, Reinhard, Ho, Allen W, Peterson, Amy C, Janardhan, Sujit, Brown, Ian, Praveen, Kesavannair, Stang, Stacey, Stone, James C

Volltext

Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer von Morris, Michael J, Rathkopf, Dana E, Novotny, William, Gibbons, Jacqueline A, Peterson, Amy C, Khondker, Zakaria, Ouatas, Taoufik, Scher, Howard I, Fleming, Mark T

Volltext

Tumor progression despite massive influx of activated CD8+ T cells in a patient with malignant melanoma ascites von HARLIN, Helena, KUNA, Todd V, PETERSON, Amy C, YURU MENG, GAJEWSKI, Thomas F

Volltext

T cell development and function in CrkL‐deficient mice von Peterson, Amy C., Marks, Reinhard E., Fields, Patrick E., Imamoto, Akira, Gajewski, Thomas F.

Volltext

The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer von Knight, David, Peterson, Amy C., Rini, Brian I., Harlin, Helena, Gajewski, Thomas F., Stadler, Walter M.

Volltext

Preliminary clinical pharmacokinetics and dose-response to support a phase II dose selection for CX-2009: A masked probody drug conjugate to CD166 von Stroh, Mark, Li, Rachel, Lu, Hong, Wada, Russ, Richardson, Jennifer Hope, Frye, John W., Peterson, Amy C.

Volltext

A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma von Peterson, Amy C, Harlin, Helena, Karrison, Theodore, Vogelzang, Nicholas J, Knost, James A, Kugler, John W, Lester, Eric, Vokes, Everett, Gajewski, Thomas F, Stadler, Walter M

Volltext

Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers: Initial phase I results von Gutierrez, Martin, Long, Georgina V., Friedman, Claire Frances, Richards, Donald A., Corr, Bradley, Bastos, Bruno R., Uemura, Marc Isamu, Conkling, Paul R., Moreno, Victor, Edenfield, William Jeffery, Becerra, Carlos Roberto, Piha-Paul, Sarina Anne, Peterson, Amy C., Brown, Michelle, James, Lee P., Zheng, Ming, Jiang, Jieying, Kollia, Georgia, Swijter, Ailsa, Ascierto, Paolo Antonio

Volltext

A novel biomarker to predict sensitivity to enzalutamide (ENZA) in TNBC von Parker, Joel S., Peterson, Amy C., Tudor, Iulia Cristina, Hoffman, Jennifer, Uppal, Hirdesh

Volltext

A phase 2 single-arm study to assess clinical activity, efficacy and safety of enzalutamide (ENZA) with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer von Trudeau, Maureen E., Winer, Eric P., Steinberg, Joyce Leta, Liosatos, Maggie, Poondru, Srinivasu, Dydo, Michael Nicholas, Peterson, Amy C., Gradishar, William John

Volltext

Abstract OT3-1-06: A phase 2 single-arm study to evaluate the clinical activity, safety and tolerability of enzalutamide (ENZA) with trastuzumab in patients with advanced human gro... von Trudeau, Maureen E, Winer, Eric, Steinberg, Joyce L, Liosatos, Maggie, Poondru, Srinivasu, Dydo, Michael, Zhou, Yun, Westphal, Michael, Peterson, Amy C, Gradishar, William

Volltext

Results from a phase I study of enzalutamide in combination with docetaxel in men with prostate cancer von Fleming, Mark T., Rathkopf, Dana E., Gibbons, Jackie, Peterson, Amy C., Hannah, Alison, Forer, David, Scher, Howard I., Morris, Michael J.

Volltext

A randomized, open-label, phase II study of MDV3100 alone or in combination with leuprolide and dutasteride as neoadjuvant therapy to prostatectomy in intermediate and high-risk pr... von Montgomery, Robert B., Joshua, Anthony, Hannah, Alison L., Peterson, Amy C., Lopez, Christian, Gleave, Martin Edwin, Taplin, Mary-Ellen

Volltext